Study of the Usefulness of p16 Immunostaining and EBER-ISH for Primary Unknown Carcinoma with Cervical Neck Lymph Node Metastasis-Reference-Cited by-同舟云学术

Study of the Usefulness of p16 Immunostaining and EBER-ISH for Primary Unknown Carcinoma with Cervical Neck Lymph Node Metastasis

Published:2022-10-20 Issue:10 Volume:125 Page:1472-1479
ISSN:2436-5793
Container-title:Nippon Jibiinkoka Tokeibugeka Gakkai Kaiho(Tokyo)
language:en
Short-container-title:

Author:

Sekimizu Mariko¹,Mikoshiba Takuya¹,Nagai Ryoto¹,Takebayashi Akiko¹,Saito Shin¹,Nakamura Shintaro²,Kameyama Kaori³,Ozawa Hiroyuki¹

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery, Keio University School of Medicine

2. Department of Otolaryngology, Kitasato University Kitasato Institute Hospital

3. Department of Pathology, Showa University Northern Yokohama Hospital

Publisher

Oto-Rhino-Laryngological Society of Japan, Inc.

Link

https://www.jstage.jst.go.jp/article/jibiinkotokeibu/125/10/125_1472/_pdf

Reference27 articles.

1. 1) Grau C, Johansen LV, Jakobsen J, et al: Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology. Radiother Oncol 2000; 55: 121-129.

2. 2) Schmalbach CE, Miller FR: Occult primary head and neck carcinoma. Curr Oncol Rep 2007; 9: 139-146.

3. 3) Keller LM, Galloway TJ, Holdbrook T, et al: p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in head and neck squamous cell carcinomas of unknown primary. Head Neck 2014; 36: 1677-1684.

4. 4) Galloway TJ, Ridge JA: Management of squamous cancer metastatic to cervical nodes with an unknown primary site. J Clin Oncol 2015; 33: 3328-3337.

5. 5) NCCN Clinical Practice Guidelines in Oncology : Head and Neck Cancers. http: //www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf, 参照 (2021-12-11).